2.82
-0.68 (-19.43%)
| 前收盘价格 | 3.50 |
| 收盘价格 | 3.38 |
| 成交量 | 48,763 |
| 平均成交量 (3个月) | 51,144 |
| 市值 | 176,012,272 |
| 价格/销量 (P/S) | 0.290 |
| 股市价格/股市净资产 (P/B) | 12.93 |
| 52周波幅 |
| 营业毛利率 | -30.61% |
| 营业利益率 (TTM) | -4.54% |
| 稀释每股收益 (EPS TTM) | -3.68 |
| 季度收入增长率 (YOY) | 11.50% |
| 总债务/股东权益 (D/E MRQ) | 512.62% |
| 流动比率 (MRQ) | 0.900 |
| 营业现金流 (OCF TTM) | -5.99 M |
| 杠杆自由现金流 (LFCF TTM) | 50.49 M |
| 资产报酬率 (ROA TTM) | -10.94% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 看跌 | 看跌 |
| Diagnostics & Research (全球的) | 看跌 | 看跌 | |
| 股票 | Atlantic International Corp. | - | - |
AIStockmoo 评分
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | -1.63 |
|
Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Core |
| 内部持股比例 | 82.98% |
| 机构持股比例 | 0.30% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合